Clinical trials in the wake of Vioxx: requiring statistically extreme evidence of benefit to ensure the safety of new drugs.
Roth-Cline
Michelle D
MD
Department of Statistics, University of Wisconsin, Madison, WI 53792, USA. mdrothcline@wisc.edu